Quantcast
Free Trial!
Today’s Best Stocks To Trade!  Click Here


 

The SI Report: Global Market Review for Paladin Labs Inc.

Friday, February 29, 2008; Posted: 05:11 AM
Stocks RSS
7 Stocks You Need To Know For Tomorrow -- Free Newsletter
Feb 29, 2008 (M2 PRESSWIRE via COMTEX) -- PLDLF | news | PowerRating | PR Charts -- Streetinvesting.com has now resumed our progressive review of Paladin Labs Inc. (TSX:PLB) after it traded up 9% Thursday, late in the afternoon with above average volume. Based on the Company's most recent news release, we will be progressively reviewing the impact of the markets and the effects of their developments.

Make sure to visit www.streetinvesting.com to keep updated and signup for free with no credit card for market reports and analytical plays.

Our research resources have been aimed towards the Canadian Caps and the various prospective companies therein Paladin Labs Inc. was among those that we have been closely examining due to their recent news and trading patterns.

February 28, 2008 Paladin Labs Inc. (TSX:PLB) reported its financial results for the fourth quarter and year ended December 31, 2007. The Company achieved record revenues for the fourth quarter of 2007 and has achieved its 12th consecutive year of record revenues.

Revenues for the fourth quarter of 2007 increased 24% to a record $17.7 million compared to $14.3 million in the fourth quarter of 2006. Revenues from the Company's key promoted brands including: Twinject , Oxytrol , Plan B , Trelstar , Pennsaid , Metadol , Testim and Tridural(TM) increased by 39% in the fourth quarter of 2007 compared to the same period a year ago. For the year ended December 31, 2007, revenues increased 30% to a record $62.9 million compared to $48.4 million in 2006.

Paladin Labs Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian market. With this strategy, a focused national sales team and proven marketing expertise, Paladin has evolved into one of Canada's leading specialty pharmaceutical companies. For more information, please visit the Company's web site at www.paladinlabs.com.

Streetinvesting.com will continue to follow the progress of this company following their most recent news announcement. Visit www.streetinvesting.com and signup free for our financial market services.

At Streetinvesting.com, we bring our knowledge of the marketplace and investment opportunities directly to our subscribers. As an aggressive-growth research company, our strength and goal is bringing distinctive trading opportunities and investment philosophies to investors seeking a different and unique approach to investment ideas. That's our goal. That's what we do. We are "The Word on the Street".

Let us become your number one portal for research and information on the global markets.

To continue with the more in-depth analysis, please visit www.streetinvesting.com for a complimentary subscription to access this report and other related articles. Please note that membership does not require credit card information.

All material herein was prepared by Streetinvesting.com, (Street Investing) based upon information believed to be reliable. The information contained herein is not guaranteed by Streetinvesting.com to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Streetinvesting.com is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. Streetinvesting.com may receive compensation in cash or shares from independent third parties or from the companies mentioned.

Streetinvesting.com's affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value.

Streetinvesting.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.

You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and Streetinvesting.com undertakes no obligation to update such statements.

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

For full details for PLB click here.
Morning Coffee with TradingMarkets -- Free Newsletter

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Most Popular News
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2008 The Connors Group, Inc.